Objective. To investigate whether use of adalimumab decreases the frequency of attacks of
anterior uveitis (AU) in patients with ankylosing spondylitis (AS). Methods. Consecutive …

The aim of this cohort study was to evaluate the long‐term effects of TNF inhibitors (TNFis) on
BMD and the incidence of vertebral fractures (VFxs) in patients with ankylosing spondylitis (…

Objective To assess gender differences in body composition (BC) in a cohort of AS patients
naïve to TNF-α blockers. Methods Patients included fulfilled the Modified New York criteria …

Objective. Our main objective was to assess the relationship between body composition (BC)
and response to tumor necrosis factor-α (TNF-α) blocker treatment in patients with …

Objective C-reactive protein (CRP) levels are frequently used to determine disease activity
in patients with ankylosing spondylitis (AS), but these levels may not reflect disease activity. …

Objective To examine the prevalence of hip involvement between sexes in patients with
ankylosing spondylitis (AS) treated with tumor necrosis factor inhibitors (TNFi) and to estimate …

Background and aims Rheumatoid arthritis (RA) patients are currently treated with
biological agents mostly aimed at cytokine blockade, such as tumor necrosis factor-alpha (TNFα). …

Objective To study changes in retention of first biologic disease-modifying antirheumatic
drug (DMARD) therapy over a period of 15 years in an inception cohort of patients with …

3 Boekel L, Steenhuis M, Hooijberg F, et al. Antibody development after COVID-19 vaccination
in patients with autoimmune diseases in the Netherlands: a substudy of data from two …

Objective To observe long-term clinical response and drug survival in a prospective two-year
cohort study in rheumatoid arthritis (RA) patients starting adalimumab or etanercept …